Hope for rare gut cancer: trial tests 'Smart Bomb' drug
NCT ID NCT07347314
Summary
This study is testing a new drug called enfortumab vedotin for people with advanced small bowel cancer that has stopped responding to standard chemotherapy. The drug is designed to target a specific protein found on many of these cancer cells. Researchers will give the drug to about 27 patients to see if it shrinks tumors and is safe to use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SMALL BOWEL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kyushu University Hospital
RECRUITINGFukuoka, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Cancer Center Hospital
RECRUITINGTokyo, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Osaka International Cancer Institute
NOT_YET_RECRUITINGOsaka, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.